Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B01AF01	RIBAVAN	G	Rivaroxaban - 2.5mg	2.5mg	Tablet, film coated	3,199,625 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 15	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,164,664 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 20	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,164,664 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	959,888 L.L
B01AF01	RIXALTA 10	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	671,921 L.L
B02BD02	RECOMBINATE	BioTech	Coagulation Factor VIII recombinant (Octocog alfa) - 250IU	250IU	Injectable powder for solution+diluent	8,140,612 L.L
B02BD02	RECOFACT VIII	BioTech	Moroctocog alfa - 500IU	500IU	Injectable powder for solution+diluent	12,049,005 L.L
B02BD02	RECOMBINATE	BioTech	Coagulation Factor VIII recombinant (Octocog alfa) - 500IU	500IU	Injectable powder for solution+diluent	575,319 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	1,312,563 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	2,832,997 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	5,665,526 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	800,628 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	47,533,131 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	1,284,239 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	1,284,239 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	2,350,571 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	2,350,571 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	78,295,560 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	78,295,560 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	143,306,217 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	143,306,217 L.L
B05BB01	RINGER'S INJECTION USP	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	199,957 L.L
B05BB01	RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	161,314 L.L
B05BB01	RINGER'S INJECTION USP	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	129,934 L.L
B05BB01	RINGER'S INJECTION USP	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	205,933 L.L
B05BB01	RINGER'S INJECTION USP	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	224,565 L.L
B05BB01	RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	180,437 L.L
B05BB01	RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	154,450 L.L

...